pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 13·1 min read
save

Merck KGaA sees client stockpiling of lab equipment amid Iran war, lifts guidance

May 13, 2026·read at Endpoints ↗Positive

Merck KGaA's CFO Helene von Roeder said the company is observing a rise in demand for its laboratory equipment as customers increase inventories in response to the ongoing war in Iran.

The heightened purchasing activity reflects concerns about potential supply disruptions, prompting pharmaceutical manufacturers and research labs to secure essential instruments.

The surge in orders has contributed to a stronger outlook for Merck KGaA, helping the firm raise its financial guidance for the current year.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boost”

read at Endpoints ↗
92 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Merck KGaA5

related stories

  • 4d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Oct 1STAT+: In Shanghai’s ‘Science City,’ China’s ascendant biotechs make their pitch to the worldSTAT
  • Sep 30FDA starts review of Roche’s multiple sclerosis pillBioPharma Dive
  • Sep 22Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with EnvisagenicsBioSpace
  • Sep 18BMS scraps Orum’s targeted degrader after reviewing Phase 1 dataBioSpace